Clinical Trial Update: A Study to Determine the Excretion Balance and Pharmacokinetics of 14C-GSK573719 [Phase 1]

View source ↗

Summary

Phase 1 study to determine excretion balance and pharmacokinetics of 14C-labeled GSK573719 in chronic obstructive pulmonary disease; the trial status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK573719 (14C-labeled) (GSK573719)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED